page_title: Tecemotide
section_title: Structure
hierarchical_section_title: Tecemotide / Structure
caption_attribution_description: Deutsch: Schematische Darstellung des Aufbaus von Stimuvax (L-BPL-25). English: Schematic drawing of BPL-25 (Stimuvax). The BLP25 lipopeptide and monophosphoryl lipid A (MPL) are associated with the lipid bilayer of the liposomes that are formed upon rehydration of the dry powder.
context_page_description: Tecemotide is a synthetic lipopeptide that is used as antigen in an investigational therapeutic cancer vaccine. The investigational therapeutic cancer vaccine is designed to induce a cellular immune response to cancer cells that express MUC1, a glycoprotein antigen that is widely over-expressed on common cancers such as lung cancer, breast cancer, prostate cancer and colorectal cancer. The cellular immune response may lead then to a rejection of tumor tissue expressing the MUC1 antigen.
caption: Structure of the cancer vaccine. The antigen tecemotide (orange) and the adjuvant MPL (dark blue) are anchored in the membrane of the liposome. The liposome is formed by the lipids (light blue).[6]
exif: {}